Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334061 · ClinicalTrials.gov registry record · Phase 2
Study to Assess the Safety and Effectiveness of the Penumbra System
A Phase 2 study, sponsored by Penumbra.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT00334061: Completed Phase 2 study, sponsored by Penumbra.
NCT00334061 is a Phase 2 study that has completed, run by Penumbra. The registered enrollment target is 125 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00334061, a Phase 2 study, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This clinical evaluation is a prospective, single-arm, multi-center trial. The purpose of this clinical evaluation is to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occlusive disease.
Primary Outcome
Revascularization is defined by a Thrombolysis in Myocardial Infarction (TIMI) score of 2 or 3 following use of the Penumbra System. TIMI scores are used to describe blood flow at the treated vessel with 0 designating no flow and 3 for normal flow.
Interventions
- DEVICE Penumbra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
What the finished NCT00334061 record still lists
NCT00334061 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Penumbra System is the first listed.
NCT00334061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00334061 about?
NCT00334061 is a clinical study titled "Study to Assess the Safety and Effectiveness of the Penumbra System". This clinical evaluation is a prospective, single-arm, multi-center trial. The purpose of this clinical evaluation is to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occ...
What is the current status of trial NCT00334061?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2006-06. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00334061?
The interventions under investigation include: Penumbra System (DEVICE).
Who is sponsoring clinical trial NCT00334061?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00334061's enrollment target sits among peer trials
125 558th of 2000 higher than 1,437 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia